596 related articles for article (PubMed ID: 35406785)
21. The role of cellular senescence in female reproductive aging and the potential for senotherapeutic interventions.
Secomandi L; Borghesan M; Velarde M; Demaria M
Hum Reprod Update; 2022 Feb; 28(2):172-189. PubMed ID: 34918084
[TBL] [Abstract][Full Text] [Related]
22. Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications.
Chandrakar L; Ambatwar R; Khatik GL
Curr Top Med Chem; 2024; 24(2):157-178. PubMed ID: 38037999
[TBL] [Abstract][Full Text] [Related]
23. Exploring the role of senescence inducers and senotherapeutics as targets for anticancer natural products.
Mamun AA; Sufian MA; Uddin MS; Sumsuzzman DM; Jeandet P; Islam MS; Zhang HJ; Kong AN; Sarwar MS
Eur J Pharmacol; 2022 Aug; 928():174991. PubMed ID: 35513016
[TBL] [Abstract][Full Text] [Related]
24. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
Lagoumtzi SM; Chondrogianni N
Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
[TBL] [Abstract][Full Text] [Related]
25. Senotherapeutics and HIV-1 Persistence.
Szaniawski MA; Spivak AM
Curr HIV/AIDS Rep; 2020 Jun; 17(3):219-225. PubMed ID: 32356089
[TBL] [Abstract][Full Text] [Related]
26. Obesity, Senescence, and Senolytics.
Chaib S; Tchkonia T; Kirkland JL
Handb Exp Pharmacol; 2022; 274():165-180. PubMed ID: 34697668
[TBL] [Abstract][Full Text] [Related]
27. The implication of ROCK 2 as a potential senotherapeutic target via the suppression of the harmful effects of the SASP: Do senescent cancer cells really engulf the other cells?
Şimay Demir YD; Özdemir A; Sucularlı C; Benhür E; Ark M
Cell Signal; 2021 Aug; 84():110007. PubMed ID: 33845155
[TBL] [Abstract][Full Text] [Related]
28. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans.
Zhu Y; Prata LGPL; Gerdes EOW; Netto JME; Pirtskhalava T; Giorgadze N; Tripathi U; Inman CL; Johnson KO; Xue A; Palmer AK; Chen T; Schaefer K; Justice JN; Nambiar AM; Musi N; Kritchevsky SB; Chen J; Khosla S; Jurk D; Schafer MJ; Tchkonia T; Kirkland JL
EBioMedicine; 2022 Mar; 77():103912. PubMed ID: 35292270
[TBL] [Abstract][Full Text] [Related]
29. Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care.
Thompson EL; Pitcher LE; Niedernhofer LJ; Robbins PD
Plast Reconstr Surg; 2022 Oct; 150():12S-19S. PubMed ID: 36170431
[TBL] [Abstract][Full Text] [Related]
30. Piperine: An Anticancer and Senostatic Drug.
Lim JS; Lee DY; Lim JH; Oh WK; Park JT; Park SC; Cho KA
Front Biosci (Landmark Ed); 2022 Apr; 27(4):137. PubMed ID: 35468696
[TBL] [Abstract][Full Text] [Related]
31. Senescence and the SASP: many therapeutic avenues.
Birch J; Gil J
Genes Dev; 2020 Dec; 34(23-24):1565-1576. PubMed ID: 33262144
[TBL] [Abstract][Full Text] [Related]
32. The costs and benefits of senotherapeutics for human health.
Raffaele M; Vinciguerra M
Lancet Healthy Longev; 2022 Jan; 3(1):e67-e77. PubMed ID: 36098323
[TBL] [Abstract][Full Text] [Related]
33. Cellular senescence and senolytics: the path to the clinic.
Chaib S; Tchkonia T; Kirkland JL
Nat Med; 2022 Aug; 28(8):1556-1568. PubMed ID: 35953721
[TBL] [Abstract][Full Text] [Related]
34. Senotherapeutics: Targeting senescent cells for the main age-related diseases.
Boccardi V; Mecocci P
Mech Ageing Dev; 2021 Jul; 197():111526. PubMed ID: 34166689
[TBL] [Abstract][Full Text] [Related]
35. Targeting normal and cancer senescent cells as a strategy of senotherapy.
Sikora E; Bielak-Zmijewska A; Mosieniak G
Ageing Res Rev; 2019 Nov; 55():100941. PubMed ID: 31408714
[TBL] [Abstract][Full Text] [Related]
36. Skeletal muscle aging, cellular senescence, and senotherapeutics: Current knowledge and future directions.
Englund DA; Zhang X; Aversa Z; LeBrasseur NK
Mech Ageing Dev; 2021 Dec; 200():111595. PubMed ID: 34742751
[TBL] [Abstract][Full Text] [Related]
37. Cellular senescence: the good, the bad and the unknown.
Huang W; Hickson LJ; Eirin A; Kirkland JL; Lerman LO
Nat Rev Nephrol; 2022 Oct; 18(10):611-627. PubMed ID: 35922662
[TBL] [Abstract][Full Text] [Related]
38. Promises and challenges of senolytics in skin regeneration, pathology and ageing.
Pils V; Ring N; Valdivieso K; Lämmermann I; Gruber F; Schosserer M; Grillari J; Ogrodnik M
Mech Ageing Dev; 2021 Dec; 200():111588. PubMed ID: 34678388
[TBL] [Abstract][Full Text] [Related]
39. Senolytic and senomorphic interventions to defy senescence-associated mitochondrial dysfunction.
Nehlin JO
Adv Protein Chem Struct Biol; 2023; 136():217-247. PubMed ID: 37437979
[TBL] [Abstract][Full Text] [Related]
40. New Horizons in cellular senescence for clinicians.
Witham MD; Granic A; Miwa S; Passos JF; Richardson GD; Sayer AA
Age Ageing; 2023 Jul; 52(7):. PubMed ID: 37466640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
